Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: Role of opsonizing anti-β2-glycoprotein I antibodies

Arthritis and Rheumatism

Volumn 42, Issue 7, 1999, Pages 1412-1420

  Rovere, Patrizia ^a   Sabbadini, Maria Grazia ^a   Vallinoto, Cristina ^a   Fascio, Umberto ^a   Rescigno, Maria ^b   Crosti, Mariacristina ^c   Ricciardi Castagnoli, Paola ^b   Balestrieri, Genesio ^d   Tincani, Angela ^d   Manfredi, Angelo A ^a,e  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d SPEDALI CIVILI   (Italy)

^e Spedali Civili ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; OVALBUMIN;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; COMPLEX FORMATION; DENDRITIC CELL; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; OPSONIZATION; PRIORITY JOURNAL; SUPERNATANT; ULTRAVIOLET RADIATION;

ANTIBODIES; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; BETA 2-GLYCOPROTEIN I; CELL LINE; DENDRITIC CELLS; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; MICROSCOPY, CONFOCAL; OPSONIN PROTEINS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033496383     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199907)42:7<1412::AID-ANR15>3.0.CO;2-T     Document Type: Article

References (55)

1. Casiano CA, Tan EM. Recent developments in the understanding of antinuclear antibodies. Int Arch Allergy Immunol 1996;114: 308-13.
2. Vaishnaw AK, McNally JD, Elkon KB. Apoptosis in the rheumatic diseases. Arthritis Rheum 1997;40:1917-27.
3. Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998;41:1152-60.
4. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-34.
5. Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1996;184:765-70.
6. Casciola-Rosen LA, Nicholson DW, Chong T, Rowan KR, Thornberry N, Miller DK, et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996;183:1957-64.
7. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997;185:843-54.
8. Utz PJ, Hottelet M, van Venrooij WJ, Anderson P. Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex. J Exp Med 1998;187:547-60.
9. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179:1317-30.
10. Biggiogera M, Bottone MG, Martin TE, Uchiumi T, Pellicciari C. Still immunodetectable nuclear RNPs are extruded from the cytoplasm of spontaneously apoptotic thymocytes. Exp Cell Res 1997;234:512-20.
11. Mohan C, Adams S, Stanik V, Datta SK. Nucleosomes: a major immunogen for pathogenic autoantibody inducing T cells of lupus. J Exp Med 1993;177:1367-81.
12. Amoura Z, Chabre H, Koutouzov S, Lotton C, Kabrespines A, Bach J-F, et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994;37:1684-8.
13. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
14. Ogawa N, Dang H, Kong L, Anaya J-M, Liu GT, Talal N. Lymphocyte apoptosis and apoptosis-associated gene expression in Sjögren's syndrome. Arthritis Rheum 1996;39:1875-85.
15. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-92.
16. Triplett DA. Antiphospholipid antibodies and thrombosis: a consequence, coincidence or cause? Arch Pathol Lab Med 1993;117: 78-88.
17. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996;39:1444-54.
18. Moore JE, Lutz WB. The natural history of systemic lupus erythematosus: an approach to its study through chronic biological false positive reactors. J Chronic Dis 1955;1:297-316.
19. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994;83:372-7.
20. Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, et al. Anti-phospholipid antibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner. J Immunol 1996;157:2201-8.
21. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced pro-coagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1996;93:1624-9.
22. Manfredi AA, Rovere P, Galati G, Heltai S, Bozzolo E, Soldini L, et al. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998;41:205-14.
23. 2-glycoprotein I. Arthritis Rheum 1998;41:215-23.
24. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-6.
25. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson P. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-β, PGE2 and PAF. J Clin Invest 1998;101:890-8.
26. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1998;390: 350-7.
27. Ren Y, Savill J. Apoptosis: the importance of being eaten. Cell Death Differ 1998;5:563-8.
28. Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti MP, et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol 1997;159:5391-9.
29. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-6.
30. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
31. Thomas R, Lipsky PE. Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis. Arthritis Rheum 1996;39:183-90.
32. Albert ML, Sauter B, Bhardway N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-9.
33. Heath WR, Kurts C, Miller JFAP, Carbone FR. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 1998;187:1549-53.
34. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, et al. Bystander apoptosis triggers dendritic cell maturation and antigen presenting function. J Immunol 1998;4467-71.
35. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, et al. Maturation stages of mouse dendritic cells in growth-factor-dependent long-term cultures. J Exp Med 1997;185:317-28.
36. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble proteins into the class I pathway of antigen processing and presentation. Cell 1988;54:777-85.
37. Meek KR, Walsh A, Palmiter RD. The signal sequence of ovalbumin is located near the NH2 terminus. J Biol Chem 1982;257:12245-52.
38. Karttunen J, Sanderson S, Shastri N. Detection of rare antigen presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci USA 1992;89:6020-4.
39. Rovere P, Clementi E, Ferrarini M, Heltai S, Sciorati C, Sabbadini MG, et al. CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone γδ T cells. J Immunol 1996;156:4631-7.
40. Tincani A, Spatola L, Prati E, Allegri F, Ferremi P, Cattaneo R, et al. The anti-beta 2 glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta 2 glycoprotein I and preserved during species evolution. J Immunol 1996;157:5732-8.
41. 2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684-93.
42. Rovere P, Zimmermann VS, Forquet F, Demandolx D, Trucy J, Ricciardi-Castagnoli P, et al. Dendritic cell maturation and antigen presentation in the absence of invariant chain. Proc Natl Acad Sci U S A 1998;95:1067-72.
43. Rescigno M, Citterio S, Thery C, Rittig M, Medaglini D, Pozzi G, et al. Bacterial-induced neo-biosynthesis, stabilization and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A 1998;95:5229-34.
44. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787-92.
45. Rovere P, Manfredi AA, Vallinoto C, Zimmermann VS, Fascio U, Balestrieri G, et al. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-β2-glycoprotein I antibodies. J Autoimmun 1998;11:403-11.
46. Watts C. Capture and processing of exogenous antigen for presentation by MHC molecules. Annu Rev Immunol 1997;15:821-50.
47. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from non lymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor and interleukin 1. J Exp Med 1995;181:2237-47.
48. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994;12:991-1045.
49. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
50. Koch F, Stanzl U, Jennewein P, Janke K, Heufle C, Kampgen E, et al. High levels of IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J Exp Med 1996;184:741-6.
51. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995;181:839-44.
52. Bordron A, Dueymes M, Levy Y, Jamin C, Ziporen L, Piette J-C, et al. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum 1998;41:1738-47.
53. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
54. Carroll MC. The lupus paradox. Nat Genet 1998;19:3-4.
55. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998;188:2313-20.